Wordt geladen...
Improving CAR T cell immunotherapy–mediated remissions for pediatric leukemia
Chimeric antigen receptor (CAR) T cells are an effective therapy for relapsed or refractory pediatric B cell leukemia. Analysis of the starting material, the T cells collected from the patient prior to CAR manufacture, reveals possible biomarkers of cells destined to perform poorly in patients. Long...
Bewaard in:
| Gepubliceerd in: | J Clin Invest |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486350/ https://ncbi.nlm.nih.gov/pubmed/30985293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI128743 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|